- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting TGF-β Signaling in Kidney Fibrosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 9, Pages 2532
Publisher
MDPI AG
Online
2018-08-27
DOI
10.3390/ijms19092532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Anti–TGF-βTherapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach
- (2017) Steve McGaraughty et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF- β 1/Smad3 Pathway
- (2017) Ruijie Liu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Targeting gene expression to specific cells of kidney tubules in vivo, using adenoviral promoter fragments
- (2017) Sumiyo Watanabe et al. PLoS One
- PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling
- (2016) Xia Lin et al. CELL
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- TRAF6 Stimulates the Tumor-Promoting Effects of TGF Type I Receptor Through Polyubiquitination and Activation of Presenilin 1
- (2014) S. K. Gudey et al. Science Signaling
- Transforming Growth Factor β-1 Stimulates Profibrotic Epithelial Signaling to Activate Pericyte-Myofibroblast Transition in Obstructive Kidney Fibrosis
- (2012) Ching-Fang Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3
- (2012) Kazunori Inoue et al. LABORATORY INVESTIGATION
- A systems approach identifies HIPK2 as a key regulator of kidney fibrosis
- (2012) Yuanmeng Jin et al. NATURE MEDICINE
- Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro
- (2011) Xiao-Ming Meng et al. JOURNAL OF PATHOLOGY
- Pirfenidone for Diabetic Nephropathy
- (2011) K. Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
- (2011) Howard Trachtman et al. KIDNEY INTERNATIONAL
- TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer
- (2011) Yabing Mu et al. Nature Communications
- Tubular Overexpression of Transforming Growth Factor-β1 Induces Autophagy and Fibrosis but Not Mesenchymal Transition of Renal Epithelial Cells
- (2010) Robert Koesters et al. AMERICAN JOURNAL OF PATHOLOGY
- Intraglomerular expression of transforming growth factor-beta 1 (TGF-β1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction
- (2010) M. IWANO et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- Transforming growth factor-β2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-β2 by impeding CTGF expression
- (2009) Shuyu Ren et al. KIDNEY INTERNATIONAL
- Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
- (2007) Gerald S. Horan et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started